Clotblog with Dr Samuel Goldhaber
View all posts »Statins and diabetes: Reviewing JUPITER with Dr Paul Ridker
Aug 10, 2012 08:50 EDT-
2Comments
-
Read later
Following the publication of his recent Lancet paper, Dr Paul Ridker joins Dr Goldhaber to discuss how the JUPITER data add to the debate.
See also:
- Ridker PM et al. Cardiovascular benefits and diabetes risk of statin therapy in primary prevention: An analysis of the JUPITER trial. Lancet 2012; 380:565-571. Abstract.
- JUPITER analysis helps assuage fears about diabetes risk with statins
- Statins, diabetes, and the FDA
- Life and times of leading cardiologists with Rob Califf. Guest: Paul Ridker
Your comments
|
||||
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|||
You must be a member (with full membership) to post a comment.
Already a member?
Enjoy all the benefits of theheart.org
With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.
Membership is free!












